Penn's Gynecologic Oncology Research Program Studies Immune Therapy in Ovarian Cancer


September 6, 2006

PENN Online Today

Only 40 percent of women who are diagnosed with advanced ovarian cancer survive longer than five years. Finding new and effective treatments for advanced ovarian cancer is critical. Penn's Gynecologic Oncology Research Program is at the forefront of research advances in the field, finding more encouraging treatment options for women with gynecologic cancer than ever before... Read More